DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Thrombopoietin mimetics
Thrombopoietin mimetics
Thrombocytopenia
Haematopoiesis During Native Conditions and Immune Thrombocytopenia Progression
SIMPLIFY-1: a Phase III Randomized Trial of Momelotinib Versus Ruxolitinib in Janus Kinase Inhibitor-Naive Patients with Myelofibrosis Ruben A
Mpl Expression on Megakaryocytes and Platelets Is Dispensable for Thrombopoiesis but Essential to Prevent Myeloproliferation
Improving Outcomes of Chemotherapy: Established and Novel Options for Myeloprotection in the COVID-19 Era
Safety of Bloodless Autologous Stem Cell Transplantation in Jehovah's Witness Patients
Moving Towards a New Era in the Management of Chronic Immune Thrombocytopenia Hans Wadenvik, Bob Olsson
Page 1 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19
Platelets-Purpose-Pi
Essai Clinique Généré Le 26 Sept
Chemotherapy-Induced Myelosuppression in Patients with Small Cell Lung Cancer: What’S New?
Portal Vein Thrombosis As Complication of Romiplostim Treatment in a Cirrhotic Patient with Hepatitis C-Associated Immune Thrombocytopenic Purpura
Review Article: Thrombocytopenia in Chronic Liver Disease F
Eltrombopag for the Treatment of Chronic Immune Thrombocytopenia
Thrombopoietin from Hepatocytes Promotes Hematopoietic Stem Cell Regeneration After
© Ferrata Storti Foundation
New Small Molecule Drugs for Thrombocytopenia: Chemical, Pharmacological, and Therapeutic Use Considerations
Considerations for Use of Hematopoietic Growth Factors in Patients with Cancer Related to the COVID-19 Pandemic
Top View
Study Protocol and Statistical Analysis Plan
Management of Thrombocytopenia Due to Liver Cirrhosis: a Review
Romiplostim and Eltrombopag for Immune Thrombocytopenia: Methods for Indirect Comparison
Oregon Drug Use Review / Pharmacy & Therapeutics Committee
Non Commercial Use Only
Considerations in the Management of Hepatitis C Virus-Related Thrombocytopenia with Eltrombopag Fazal A